Skip to Content

JSP 519 (Levothyroxine 125 mcg (0.125 mg))

Pill imprint JSP 519 has been identified as Levothyroxine sodium 125 mcg (0.125 mg).

Levothyroxine is used in the treatment of hashimoto's disease; underactive thyroid; hypothyroidism, after thyroid removal; tsh suppression; thyroid suppression test (and more), and belongs to the drug class thyroid drugs. Studies show no risk during pregnancy. Levothyroxine 125 mcg (0.125 mg) is not a controlled substance under the Controlled Substance Act (CSA).

Levothyroxine sodium 125 mcg (0.125 mg) JSP 519
Levothyroxine sodium 125 mcg (0.125 mg) JSP 519 Front
Levothyroxine sodium 125 mcg (0.125 mg) JSP 519 Back
Discount Card Promo
Levothyroxine sodium
JSP 519
125 mcg (0.125 mg)
7.00 mm
Prescription only
Drug Class:
Thyroid drugs
Pregnancy Category:
A - Studies show no risk
CSA Schedule:
Not a controlled drug
Lannett Company, Inc.
National Drug Code (NDC):
Inactive Ingredients:
silicon dioxide
magnesium stearate
microcrystalline cellulose
corn starch
sodium starch glycolate type A potato
FD&C Yellow No. 6
FD&C Red No. 40
FD&C Blue No. 1
aluminum oxide

Note: Inactive ingredients may vary.

Imprint Code FAQ's

Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
00527-1376 Lannett Company, Inc.
00527-1376 Lannett Company, Inc.
66336-0752 Dispensing Solutions Inc. (repackager)
21695-0754 Rebel Distributors Corp (repackager)

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.